Nomination Committee
Mr. Vijay Karwal
Mr. Vijay Karwal
  • Independent Director
  • Member of Audit Committee
  • Chair of Nomination Committee
Back

The Age (as on Dec 31, 2022)

  • 52 Years

Education

  • 1997 - 1999 CFA Institute, Current holder of Chartered Financial Analyst (CFA) designation
  • 1988 - 1994 University of Groningen, The Netherlands, M.Sc. in Monetary Economics
  • 1993 - 1994 University of Southampton, United Kingdom, Erasmus Scholar - Department of Accounting & Management Sciences

Shares held by each director (as on Dec 31, 2022)

  • None

Experiences in the past 5 Years

  • 2021 - Present

    Director, Independent Director, Member of Audit Committee and Chairman of Nomination and Remuneration Committee Mega Lifesciences PCL/Manufacture and distribute nutraceutical and pharmaceutical products

  • 2021 - Present

    Chief Financial Officer AffaMed Therapeutics, Hong Kong / developing and commercializing transformative pharmaceutical products

  • 2021 - Present

    Managing Director, Head of Healthcare Investment Banking, Asia ex-Japan Nomura International, Hong Kong

  • 2015 - 2017

    Chief Development Officer, Asia Pacific DaVita Inc., Singapore / leading global operator of dialysis clinics and integrated care services

  • 2017

    General Manager, China DaVita Inc. Shanghai

Back